TRIF Mediates Toll-Like Receptor 2-Dependent Inflammatory Responses to Borrelia burgdorferi

ABSTRACT TRIF is an adaptor molecule important in transducing signals from intracellularly signaling Toll-like receptor 3 (TLR3) and TLR4. Recently, TLR2 was found to signal from intracellular compartments. Using a synthetic ligand for TLR2/1 heterodimers, as well as Borrelia burgdorferi, which is a strong activator of TLR2/1, we found that TLR2 signaling can utilize TRIF. Unlike TRIF signaling by other TLRs, TLR2-mediated TRIF signaling is dependent on the presence of another adaptor molecule, MyD88. However, unlike MyD88 deficiency, TRIF deficiency does not result in diminished control of infection with B. burgdorferi in a murine model of disease. This appears to be due to the effects of MyD88 on phagocytosis via scavenger receptors, such as MARCO, which are not affected by the loss of TRIF. In mice, TRIF deficiency did have an effect on the production of inflammatory cytokines, suggesting that regulation of inflammatory cytokines and control of bacterial growth may be uncoupled, in part through transduction of TLR2 signaling through TRIF.

[1]  E. Cantó,et al.  Functional consequences of CD36 downregulation by TLR signals. , 2012, Cytokine.

[2]  P. Cossart,et al.  Both TLR2 and TRIF Contribute to Interferon-β Production during Listeria Infection , 2012, PloS one.

[3]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[4]  L. Kobzik,et al.  MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. , 2011, American journal of respiratory cell and molecular biology.

[5]  B. Williams,et al.  Faculty Opinions recommendation of Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. , 2011 .

[6]  R. Bronson,et al.  Nod2 Suppresses Borrelia burgdorferi Mediated Murine Lyme Arthritis and Carditis through the Induction of Tolerance , 2011, PloS one.

[7]  B. Sahay,et al.  Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-β , 2011, Proceedings of the National Academy of Sciences.

[8]  J. Blalock,et al.  CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis. , 2011, The American journal of pathology.

[9]  S. Gordon,et al.  SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. , 2011, Blood.

[10]  M. Oosting,et al.  Borrelia species induce inflammasome activation and IL‐17 production through a caspase‐1‐dependent mechanism , 2011, European journal of immunology.

[11]  Linden T. Hu,et al.  Human Integrin α3β1 Regulates TLR2 Recognition of Lipopeptides from Endosomal Compartments , 2010, PloS one.

[12]  P. Zipfel,et al.  Inadequate Binding of Immune Regulator Factor H Is Associated with Sensitivity of Borrelia lusitaniae to Human Complement , 2010, Infection and Immunity.

[13]  K. Moore,et al.  Phagocytosis and Phagosome Acidification Are Required for Pathogen Processing and MyD88-Dependent Responses to Staphylococcus aureus , 2010, The Journal of Immunology.

[14]  N. Dietrich,et al.  Murine Toll-Like Receptor 2 Activation Induces Type I Interferon Responses from Endolysosomal Compartments , 2010, PloS one.

[15]  J. Weis,et al.  The Lyme Disease Spirochete Borrelia burgdorferi Utilizes Multiple Ligands, Including RNA, for Interferon Regulatory Factor 3-Dependent Induction of Type I Interferon-Responsive Genes , 2010, Infection and Immunity.

[16]  B. Sahay,et al.  CD14 Signaling Restrains Chronic Inflammation through Induction of p38-MAPK/SOCS-Dependent Tolerance , 2009, PLoS pathogens.

[17]  I. Schwartz,et al.  Recognition of Borrelia burgdorferi, the Lyme Disease Spirochete, by TLR7 and TLR9 Induces a Type I IFN Response by Human Immune Cells1 , 2009, The Journal of Immunology.

[18]  R. Locksley,et al.  Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands , 2009, Nature Immunology.

[19]  E. Fikrig,et al.  Toll-like receptors 1 and 2 heterodimers alter Borrelia burgdorferi gene expression in mice and ticks. , 2009, The Journal of infectious diseases.

[20]  S. Biswas,et al.  Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.

[21]  Tomas Hrncir,et al.  Nod2 is required for the regulation of commensal microbiota in the intestine , 2009, Proceedings of the National Academy of Sciences.

[22]  S. Akira,et al.  Downstream Signals for MyD88-Mediated Phagocytosis of Borrelia burgdorferi Can Be Initiated by TRIF and Are Dependent on PI3K1 , 2009, The Journal of Immunology.

[23]  S. Gordon,et al.  MARCO, TLR2, and CD14 Are Required for Macrophage Cytokine Responses to Mycobacterial Trehalose Dimycolate and Mycobacterium tuberculosis , 2009, PLoS pathogens.

[24]  L. Bockenstedt,et al.  The Caspase 1 Inflammasome Is Not Required for Control of Murine Lyme Borreliosis , 2009, Infection and Immunity.

[25]  J. Radolf,et al.  Activation of Human Monocytes by Live Borrelia burgdorferi Generates TLR2-Dependent and -Independent Responses Which Include Induction of IFN-β , 2009, PLoS pathogens.

[26]  Shizuo Akira,et al.  The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.

[27]  J. Zachary,et al.  A Critical Role for Type I IFN in Arthritis Development following Borrelia burgdorferi Infection of Mice1 , 2008, The Journal of Immunology.

[28]  Shizuo Akira,et al.  Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines , 2008, Proceedings of the National Academy of Sciences.

[29]  S. Akira,et al.  Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction , 2008, Infection and Immunity.

[30]  S. Akira,et al.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.

[31]  K. Moore,et al.  Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome , 2008, The Journal of experimental medicine.

[32]  J. Radolf,et al.  Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes , 2007, Infection and Immunity.

[33]  K. Honda,et al.  Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. , 2007, Biochemical and biophysical research communications.

[34]  J. Radolf,et al.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum Potentiates Innate Immune Activation and Induces Gamma Interferon Production , 2007, Infection and Immunity.

[35]  S. Akira,et al.  Identification of a TLR-Independent Pathway for Borrelia burgdorferi-Induced Expression of Matrix Metalloproteinases and Inflammatory Mediators through Binding to Integrin α3β11 , 2006, The Journal of Immunology.

[36]  E. Fikrig,et al.  Borrelia burgdorferi Lacking BBK32, a Fibronectin-Binding Protein, Retains Full Pathogenicity , 2006, Infection and Immunity.

[37]  P. Munson,et al.  Borrelia burgdorferi Induces TLR1 and TLR2 in Human Microglia and Peripheral Blood Monocytes but Differentially Regulates HLA-Class II Expression , 2006, Journal of neuropathology and experimental neurology.

[38]  S. Akira,et al.  MyD88 Deficiency Results in Tissue-Specific Changes in Cytokine Induction and Inflammation in Interleukin-18-Independent Mice Infected with Borrelia burgdorferi , 2006, Infection and Immunity.

[39]  S. Akira,et al.  MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease1 , 2004, The Journal of Immunology.

[40]  Ruth R. Montgomery,et al.  Myeloid Differentiation Antigen 88 Deficiency Impairs Pathogen Clearance but Does Not Alter Inflammation in Borrelia burgdorferi-Infected Mice , 2004, Infection and Immunity.

[41]  Jiahuai Han,et al.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.

[42]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[43]  C. Sousa.  Faculty Opinions recommendation of TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. , 2003 .

[44]  S. Akira,et al.  Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.

[45]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[46]  E. Fikrig,et al.  Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice , 2002, Nature Medicine.

[47]  M. J. Cody,et al.  TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages , 2002, Nature Immunology.

[48]  Y. Twu,et al.  Tumor Necrosis Factor-α-mediated Protein Kinases in Regulation of Scavenger Receptor and Foam Cell Formation on Macrophage* , 2000, The Journal of Biological Chemistry.

[49]  S. Norris,et al.  Correlation between plasmid content and infectivity in Borrelia burgdorferi. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Akira,et al.  Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1 , 2000, The Journal of Immunology.

[51]  D. Golenbock,et al.  Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.

[52]  R. M. Wooten,et al.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. , 1999, Journal of immunology.

[53]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[54]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[55]  D. Levy,et al.  Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.

[56]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[57]  A. C. Nicholson,et al.  Inhibition of Macrophage Scavenger Receptor Activity by Tumor Necrosis Factor- Is Transcriptionally and Post-transcriptionally Regulated (*) , 1996, The Journal of Biological Chemistry.

[58]  J. Zachary,et al.  T cell infiltration is associated with increased Lyme arthritis in TLR2-/- mice. , 2008, FEMS immunology and medical microbiology.

[59]  R. M. Wooten,et al.  Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. , 2002, Vector borne and zoonotic diseases.